COA Statement on White House Executive Orders to Lower Drug Prices

The Community Oncology Alliance (COA) supports aspects of the Trump Administration’s efforts announced today to lower drug prices and the overall costs of health care for all Americans, while reserving judgement on other parts of the President’s plan.

COA is extremely supportive of today’s Executive Order to ensure Medicare beneficiaries receive the rebates negotiated by pharmacy benefit managers (PBMs). As President Trump noted in his remarks, PBMs are secretive corporate middlemen who provide little to no true value to patient health, yet significantly increase patient drug costs and fuel drug prices.

Continue reading on COA.